GlycoMimetics Shares Outstanding 2012-2018 | GLYC

GlycoMimetics shares outstanding from 2012 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
GlycoMimetics Annual Shares Outstanding
(Millions of Shares)
2017 29
2016 21
2015 19
2014 18
2013 1
2012 11
2011 1
GlycoMimetics Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 43
Q2 2018 43
Q1 2018 35
Q4 2017 29
Q3 2017 33
Q2 2017 27
Q1 2017 23
Q4 2016 21
Q3 2016 23
Q2 2016 20
Q1 2016 19
Q4 2015 19
Q3 2015 19
Q2 2015 20
Q1 2015 19
Q4 2014 18
Q3 2014 19
Q2 2014 20
Q1 2014 17
Q4 2013 1
Q3 2013 1
Q2 2013 1
Q1 2013 11
Q4 2012 0
Q3 2012 0
Q4 2011 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.465B $0.000B
GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.655B 11.23
Zoetis (ZTS) United States $43.591B 29.84
Grifols (GRFS) Spain $13.131B 16.02
Jazz Pharmaceuticals (JAZZ) Ireland $8.494B 12.19
Tilray (TLRY) United States $7.871B 0.00
Ionis Pharmaceuticals (IONS) United States $7.727B 0.00
Neurocrine Biosciences (NBIX) United States $6.695B 1476.60
Nektar Therapeutics (NKTR) United States $6.399B 9.17
Catalent (CTLT) United States $5.308B 22.26
Sage Therapeutics (SAGE) United States $5.188B 0.00
Impax Laboratories (AMRX) United States $4.950B 26.32
United Therapeutics (UTHR) United States $4.882B 7.98
Loxo Oncology (LOXO) United States $4.269B 0.00
TESARO (TSRO) United States $4.091B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.538B 13.10
FibroGen (FGEN) United States $3.456B 0.00
USANA Health Sciences (USNA) United States $2.989B 25.44
Endo (ENDP) Ireland $2.517B 3.86
Xencor (XNCR) United States $2.148B 0.00
Heron Therapeutics (HRTX) United States $2.082B 0.00
Corcept Therapeutics (CORT) United States $1.969B 28.90
Endocyte (ECYT) United States $1.958B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.943B 262.50
Aerie Pharmaceuticals (AERI) United States $1.848B 0.00
Zogenix (ZGNX) United States $1.845B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.778B 0.00
PTC Therapeutics (PTCT) United States $1.760B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.738B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.557B 0.00
Esperion Therapeutics (ESPR) United States $1.478B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.452B 20.43
Portola Pharmaceuticals (PTLA) United States $1.433B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.401B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.355B 0.00
Tricida (TCDA) United States $1.326B 0.00
TherapeuticsMD (TXMD) United States $0.999B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.980B 0.00
ImmunoGen (IMGN) United States $0.810B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.805B 0.00
Radius Health (RDUS) United States $0.777B 0.00
Karyopharm Therapeutics (KPTI) United States $0.634B 0.00
Collegium Pharmaceutical (COLL) United States $0.617B 0.00
Forty Seven (FTSV) United States $0.607B 0.00
Flexion Therapeutics (FLXN) United States $0.544B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.528B 0.00
ChemoCentryx (CCXI) United States $0.526B 41.64
Siga Technologies (SIGA) United States $0.513B 0.00
Akebia Therapeutics (AKBA) United States $0.510B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.475B 0.00
Dermira (DERM) United States $0.455B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.448B 26.41
Dova Pharmaceuticals (DOVA) United States $0.443B 0.00
Tyme Technologies (TYME) United States $0.434B 0.00
Odonate Therapeutics (ODT) United States $0.423B 0.00
Xeris Pharmaceuticals (XERS) United States $0.422B 0.00
KalVista Pharmaceuticals (KALV) United States $0.412B 0.00
CASI Pharmaceuticals (CASI) United States $0.411B 0.00
Translate Bio (TBIO) United States $0.406B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.393B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.384B 0.00
ArQule (ARQL) United States $0.375B 0.00
Majesco Entertainment (PTE) United States $0.347B 0.00
Aclaris Therapeutics (ACRS) United States $0.335B 0.00
Tapimmune (MRKR) United States $0.326B 0.00
Concert Pharmaceuticals (CNCE) United States $0.319B 0.00
Aratana Therapeutics (PETX) United States $0.310B 0.00
Minerva Neurosciences (NERV) United States $0.307B 0.00
OptiNose (OPTN) United States $0.294B 0.00
Mast Therapeutics (SVRA) United States $0.274B 0.00
Depomed (ASRT) United States $0.274B 10.19
Verrica Pharmaceuticals (VRCA) United States $0.266B 0.00
Aldeyra Therapeutics (ALDX) United States $0.256B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.247B 0.00
IMV INC (IMV) Canada $0.239B 0.00
Affimed (AFMD) Germany $0.238B 0.00
Ocular Therapeutix (OCUL) United States $0.235B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.217B 0.00
Galectin Therapeutics (GALT) United States $0.216B 0.00
Lannett Co Inc (LCI) United States $0.207B 1.79
Zafgen (ZFGN) United States $0.202B 0.00
Opexa Therapeutics (ACER) United States $0.199B 0.00
Aquestive Therapeutics (AQST) United States $0.197B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.189B 0.00
Calithera Biosciences (CALA) United States $0.186B 0.00
MEI Pharma (MEIP) United States $0.183B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.182B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.170B 0.00
Recro Pharma (REPH) United States $0.167B 0.00
Molecular Templates (MTEM) United States $0.166B 0.00
ContraFect (CFRX) United States $0.164B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.163B 0.00
Neon Therapeutics (NTGN) United States $0.160B 0.00
Ardelyx (ARDX) United States $0.150B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.149B 0.00
Redhill Biopharma (RDHL) Israel $0.148B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.141B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.141B 0.00
ElectroCore (ECOR) United States $0.139B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.138B 0.00
MediWound (MDWD) Israel $0.134B 0.00
Cardiome Pharma (CORV) Canada $0.132B 0.00
DURECT (DRRX) United States $0.123B 0.00
Jounce Therapeutics (JNCE) United States $0.122B 0.00
Adherex Technologies (FENC) United States $0.119B 0.00
ProNAi Therapeutics (SRRA) Canada $0.117B 0.00
Rafael Holdings (RFL) United States $0.114B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Iterum Therapeutics (ITRM) Ireland $0.103B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.098B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.094B 0.00
Immune Design (IMDZ) United States $0.093B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.089B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.086B 0.00
CTI BioPharma (CTIC) United States $0.086B 0.00
Achaogen (AKAO) United States $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Natural Alternatives (NAII) United States $0.075B 7.37
Melinta Therapeutics (MLNT) United States $0.074B 0.00
Otonomy (OTIC) United States $0.073B 0.00
KemPharm (KMPH) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
BioLineRx (BLRX) Israel $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 38.10
Neos Therapeutics (NEOS) United States $0.061B 0.00
Avenue Therapeutics (ATXI) United States $0.053B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.052B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.051B 0.00
Genocea Biosciences (GNCA) United States $0.051B 0.00
Mannatechorporated (MTEX) United States $0.047B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.040B 0.00
Novan (NOVN) United States $0.039B 0.00
ProPhase Labs (PRPH) United States $0.036B 4.08
Capnia (SLNO) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Heat Biologics (HTBX) United States $0.031B 0.00
Lipocine (LPCN) United States $0.031B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.030B 0.00
Trillium Therapeutics (TRIL) Canada $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
SCYNEXIS (SCYX) United States $0.026B 0.00
Xenetic Biosciences (XBIO) United States $0.025B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Biomerica (BMRA) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
HANCOCK JAFFE (HJLI) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.021B 0.00
Aviragen Therapeutics (VXRT) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Onconova Therapeutics (ONTX) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 6.25
ESSA Pharma (EPIX) Canada $0.016B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Shineco (TYHT) China $0.013B 1.45
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
Skyline Medical (AIPT) United States $0.009B 0.00
Aradigm (ARDM) United States $0.008B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00